Heartbeam (BEAT) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
31 Jul, 2026Opening remarks and agenda
Meeting opened virtually with a quorum present and formal agenda outlined.
Shareholders could participate and vote using a 16-digit control number; prior votes were already received.
Recording was prohibited, but a webcast playback would be available within 24 hours.
Corporate governance
Inspector of Election designated and presented oath; final report to be filed in meeting minutes.
29,050,272 shares represented in person or by proxy out of 53,506,835 shares as of record date.
All proxies checked and declared valid for voting.
Overview of voting outcomes
Seven directors elected to serve until the 2027 annual meeting or until successors are qualified.
Appointment of CBIZ CPAs P.C. as independent registered public accounting firm for 2026 approved.
Proposal to amend the 2022 Equity Incentive Plan to increase authorized shares was not approved.
Final voting totals to be announced via SEC filing and company website.
Latest events from Heartbeam
- AIMIGo nears FDA clearance as Q2 loss hits $5M, cash burn raises going concern risk.BEAT
Q2 20248 Jul 2026 - Two board nominees, including the CEO, have withdrawn from re-election with no replacements named.BEAT
Proxy filing25 Jun 2026 - Annual meeting to elect directors, ratify auditor, and expand equity plan by 3 million shares.BEAT
Proxy filing18 Jun 2026 - FDA-cleared at-home 12-lead ECG platform targets $40B market with scalable, AI-driven growth.BEAT
Investor presentation5 Jun 2026 - Annual meeting to elect directors, ratify auditor, and expand equity plan by 3 million shares.BEAT
Proxy filing5 Jun 2026 - Net loss narrowed, cash burn fell, and $11.5M funding supports clinical and commercial growth.BEAT
Q1 202613 May 2026 - FDA-cleared 12-lead ECG platform targets $40B market with at-home cardiac monitoring innovation.BEAT
Investor presentation13 May 2026 - FDA-cleared ECG tech launches with strong demand, narrowing losses, and AI-driven growth ahead.BEAT
Q4 20253 May 2026 - At-home 12-lead ECG platform launches with subscription model and AI-driven expansion.BEAT
Oppenheimer 36th Annual Healthcare MedTech & Services Conference16 Mar 2026